Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
Stopped See termination reason in detailed description.
Conditions
- Arthritis, Juvenile Rheumatoid
Interventions
- DRUG: Celecoxib
- DRUG: nsNSAIDs
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.